Introduction {#sec1-1}
============

Understanding of the cellular and molecular basis of renal development can provide insights into the mechanisms of renal disease and facilitate the development of novel regenerative medicine-based therapies. Renal development is a complex process that entails communication among multiple cell types.^[@ref1]^ At the initial stage of renal development, metanephric mesenchyme (MM) containing nephron and stromal progenitors surrounds the ureteric bud.^[@ref1]^ The MM secretes factors that stimulate branching of the ureteric bud, and cells of the ureteric bud induce MM and transform MM into cap mesenchyme, a condensed group of NP cells that surround the ureteric bud tips. Both ureteric bud and stromal progenitors contribute to the NP niche that balances self-renewal and differentiation of NPs.^[@ref4],[@ref5]^ Cells of the ureteric bud give rise to collecting ducts whereas, stromal progenitors generate vascular and interstitial cells. NPs give rise to all cell types of the nephron.^[@ref3]^

NPs, a multipotent cell population possessing full nephron-forming potential, can be identified by SIX2 and/or Cited1 expression. ^[@ref6],[@ref7]^ SIX2 plays an indispensable role in renal development and controls NP cell fate by regulating self-renewal vs. differentiation decisions; whereas, deletion of Cited1 does not impact NP compartment and renal development.^[@ref6]^ During nephrogenesis, mesenchymal NPs undergo mesenchymal to epithelial transition (MET) and generate the renal vesicle that develops first into a comma-shaped body, and then, into a Sshaped body.^[@ref1]^ S-shaped body consists of proximal, intermediate, distal and connecting segments made up of distinct precursor cell types that give rise to different nephron segments such as glomerulus, proximal convoluted tubule, Loop of Henle, distal convoluted tubule and connecting segment.^[@ref2],[@ref9]^ In-depth analyses using genetic, molecular and cellular approaches in mouse models, have defined the molecular signatures of various specialized cell types in different stages of nephron development and the molecular signals that regulate nephrogenesis. ^[@ref10],[@ref11]^ Furthermore, multiple groups have explicated methodology to isolate and expand mouse NP population in synthetic niches as well as elucidated strategies to coax these *in vitro* maintained NPs to differentiate into glomerular and tubular cell types and assemble into kidney organoids.^[@ref4],[@ref12],[@ref13]^

With the fundamental knowledge obtained from mouse models, NPs from human developing kidneys have been isolated and maintained in culture.^[@ref13],[@ref14]^ Furthermore, human NPs have been generated from induced pluripotent stem cells and developed into differentiated kidney cells and kidney organoids.^[@ref15]^ Recent studies reported detailed molecular characterization of human NPs, their nephrogenic niche and nephron patterning in the human embryonic and fetal kidneys in various stages of development.^[@ref18]^ These studies observed strong conservation in molecular markers of NPs and their derivatives as well as in pathways regulating nephrogenesis between developing mouse and human kidneys; although, a few distinct features for each species were determined as well.^[@ref19]^ Together, these experimental studies on mouse and human NPs and their development into nephrons have strong implications in the development and translation of regenerative medicine-based approaches to treat diseases requiring nephron repair and regeneration such as chronic kidney disease (CKD), increase the efficiency of *de novo* nephrogenesis and model various other renal diseases.^[@ref25],[@ref26]^

In dogs, CKD has reported prevalence of up to 25% and is one of the major causes of morbidity and mortality.^[@ref27]^ Nephron loss is one of the main underlying causes of progressive decline in renal function in CKD and ultimately leads to renal failure.^[@ref30]^ Transplantation of NPs isolated from the embryonic kidney have been shown to repair and enhance renal function in rodent models of renal injury and such NP-based therapeutic strategies have potential to address nephron loss in CKD in companion animals.^[@ref13],[@ref31],[@ref32]^ However, markers to identify and isolated canine NPs and mechanisms regulating their maintenance and differentiation into nephrons are completely unknown. This knowledge can not only help in developing novel strategies to treat CKD in dogs but also help understand the molecular basis of congenital canine diseases such renal and cystic dysplasia.^[@ref33]^ Furthermore, dogs with CKD can also serve as a large animal model for preclinical studies to test the therapeutic potential of these NP-based regenerative approaches once the fundamental knowledge about molecular mechanisms regulating canine NPs and nephrogenesis are elucidated. In the current study, we performed molecular characterization of canine NPs and their derivates in the canine fetal kidney (CFK) and found strong conservation in their expression pattern between canine, mouse and human developing kidney. This study provides a framework to identify and isolate canine NPs and will facilitate future studies for functional characterization of canine NPs.

Materials and Methods {#sec1-2}
=====================

Fetal kidney tissue isolation {#sec2-1}
-----------------------------

CFKs were collected from 11 fetuses isolated from gravid uteri isolated from three pregnant mixed breed dogs of more than 2 years of age presented from elective spay in Alabama Animal Alliance Spay Neuter Clinic, Montgomery. All the females were estimated to be in third trimester of pregnancy based upon the development of reproductive organs and claws of the fetuses. ^[@ref36],[@ref37]^ The collection and use of the tissuematerial for the current study was reviewed and approved by Tuskegee University Institutional Animal Care and Use Committee (TUIACUC) and performed according to institutional guidelines.

Hematoxylin & Eosin staining and immunofluorescence studies {#sec2-2}
-----------------------------------------------------------

Histological and immunofluorescence protocols used in the current study have been described previously.^[@ref38]^ Briefly, isolated CFKs were fixed in 4% paraformaldehyde and embedded in paraffin; 5-μm thick sections were prepared and were deparaffinized, rehydrated and subjected to Hematoxylin & Eosin (H&E) staining with the routine protocol. For immunofluorescence studies, rehydrated sections were subjected to boiling for antigen retrieval in sodium citrate buffer (10 mM sodium citrate, 0.1% Tween-20, pH 6.0) at 95°C for 30 min and then kept at room temperature for 30 min. The sections following antigenretrieval were blocked in donkey serum for at least 1 h at room temperature and incubated overnight with following primary antibodies: E-cadherin (ECAD) (1:1000, Cat \#610181; BD Biosciences, Franklin Lakes, NJ, USA), NCAM1 (1:1000, 3576; Cell Signaling Technology, Danvers, MA, USA), N-cadherin (NCAD) (1:1000, 13116; Cell Signaling), PAX2 (1:1000, 71-6000; Thermo Fisher, Rockford, IL, USA), SIX1 (1:1000, 16960; Cell Signaling), SIX2 (1:1000, 11562-1-AP; Protein Tech, Rosemont, IL, USA) and ITGA8 (1:500, AF4076; R&D Systems, Minneapolis, MN, USA), Alexa Fluor 594 and Alexa Fluor 488 secondary antibodies were used and nuclei were stained with 4′6′-diamidino-2- phenylindole. Staining was detected using Olympus fluorescence BX53F microscope (Leica, Wetzlar, Germany).

Preparation of whole cell extract from CFK and immunoblotting {#sec2-3}
-------------------------------------------------------------

To prepare whole cell lysates, kidneys isolated from dog fetuses were homogenized in RIPA lysis buffer supplemented with a protease inhibitor cocktail and rocked for 30 min at 4°C to extract proteins. To remove cell debris, solution was pelleted by centrifugation at 14,000 x g for 20 min and supernatant was used for immunoblotting. Cell lysates were fractionated by SDSPAGE, transferred to nitrocellulose membranes, and incubated with following primary antibodies at following dilutions: ECAD (1:1000), NCAM1 (1:2000), NCAD (1:1000), PAX2 (1:1000), SIX1 (1:1000), SIX2 (1:1000), and ITGA8 (1:1000). Following washing, membranes were incubated with secondary antibody conjugated with horseradish peroxidase. The proteinantibody complex was visualized with SignalFire Elit Chemiluminescent HRP substrate (Cell Signaling).

Results {#sec1-3}
=======

H&E staining of the CFK {#sec2-4}
-----------------------

First, CFK sections were stained with H&E to detect and assess NPs and other developing structures in the nephrogenic zone. Low magnification analysis revealed the nephrogenic zone in the outer renal cortex constituted predominantly by heavily hematoxylin-stained cells ([Figure 1A](#fig001){ref-type="fig"}). High magnification analysis revealed condensed cap mesenchymal cells, known to have nephron-forming potential, surrounding the ureteric bud tips ([Figure 1 B-D](#fig001){ref-type="fig"}). A subpopulation of NPs becomes committed and give rise to pretubular aggregates (PTA) that further differentiate into renal vesicles. Both PTA and renal vesicle could be seen on the sides and/or underneath the ureteric bud tips in the H&E stained sections ([Figure 1 B-D](#fig001){ref-type="fig"}). Analysis also revealed comma and S-shaped bodies, developing underneath the ureteric bud tips ([Figure 1 B-D](#fig001){ref-type="fig"}). Below the nephrogenic zone, developing renal corpuscles and tubular segments in different stages of maturation could be visualized ([Figure 1 B-D](#fig001){ref-type="fig"}). These results reveal similar progression and structural features of nephrogenesis in CFK as previously reported in the mouse and human fetal kidney.^[@ref3],[@ref22]^

![Histological analyses of the CFK. A-D) Representative images of H&E stained sections of dog fetal kidney at low (10X) and high (20X, 40X and 60X) magnification showing developing structures in the nephrogenic zone. A-D) Black arrows indicate the NP population surrounding the ureteric bud (yellow arrow); arrowheads indicate pretubular aggregates; concave arrowheads indicate renal vesicle; green colored arrows indicate S-shaped body; red arrows indicate glomeruli whereas developing tubules are indicated by blue arrows (A, B). Scale bars: A) 200 μm; B) 100 μm; C) 50 μm; D)20 μm.](ejh-63-3-3049-g001){#fig001}

SIX2/ECAD co-immunofluorescence analysis {#sec2-5}
----------------------------------------

SIX2 is a well-established marker of mesenchymal NPs that is highly conserved from mouse to human.^[@ref6],[@ref21],[@ref43]^ ECAD is expressed by the ureteric bud and NP-derivatives that are in the process of acquiring epithelial identity. To determine whether SIX2 and ECAD are expressed in the CFK, we performed western blot analysis. Both SIX2 and ECAD proteins were detected in the CFK by immunoblotting ([Figure 2 A](#fig002){ref-type="fig"},[B](#fig002){ref-type="fig"}). To determine whether SIX2 is expressed in mesenchymal nephron progenitors and how its expression changes in NP-derivates in the embryonic dog kidney, we performed co-immunofluorescence studies using antibody against SIX2 along with ECAD antiserum. For a negative control, staining with isotype control antibodies was performed that did not show any signal ([Figure 2C](#fig002){ref-type="fig"}). In sections, co-stained with SIX2 and E cadherin, strong SIX2 signal was specifically detected in the few layers of condensed mesenchymal cells surrounding the ureteric bud; and as expected, the cells with strong SIX2 signal did not show ECAD expression ([Figure 2 D-F](#fig002){ref-type="fig"}). SIX2 signal was specifically localized to the nucleus of NPs. In both pretubular aggregates and renal vesicles in the embryonic dog kidney, SIX2 expression decreased and ECAD signal could be detected indicating the advent of epithelization ([Figure 2 D-F](#fig002){ref-type="fig"}). SIX2 signal was undetectable beyond the renal vesicle stage. Ureteric bud cells that strongly expressed ECAD did not express SIX2. These results show that SIX2 marks mesenchymal canine NPs and has similar protein distribution in CFK as previously reported in mouse and human fetal kidney.^[@ref6],[@ref43],[@ref44]^

SIX2/NCAM1 co-immunofluorescence analysis {#sec2-6}
-----------------------------------------

NCAM1 is known to be expressed in NPs and their early epithelial derivatives; furthermore, its membrane localization makes it a suitable NP marker to sort cells with nephron-forming potential.^[@ref32],[@ref41],[@ref45]^ First, we determined by immunoblot analysis that NCAM1 is expressed in the CFK ([Figure 3A](#fig003){ref-type="fig"}). To determine whether SIX2-positive NPs also express NCAM1 and study the expression of NCAM1 in the early epithelial structures developing in the nephrogenic zone in the CFK, co-immunofluorescence analysis with SIX2 and NCAM1 antisera was performed. Co-staining analysis revealed that a subpopulation of highexpressing SIX2-positive cells expresses NCAM1 at their membrane ([Figure 3 B-D](#fig003){ref-type="fig"}). As NPs differentiate into a renal vesicle, SIX2 expression was dramatically reduced whereas, a strong membrane NCAM1 signal was detected in these cells. NCAM1 expression was also observed in proximal, intermediate and distal segments of the Sshaped bodies ([Figure 3 B-D](#fig003){ref-type="fig"}). In S-shaped bodies, NCAM1 signal was undetectable in podocyte precursors. Cell-surface localization of NCAM1 in SIX2-positive NP indicates that NCAM1 could be exploited to sort canine NPs. However, gentle dissociation of NPs present on the cortical surface of the kidney will be required to avoid contamination from the relatively deeper layers of NCAM1-positive early epithelial structures during sorting.

![Expression of SIX2 and ECAD in the CFK. A,B) Whole kidney extracts were prepared from CFK and subjected to Immunoblot analysis with antiserum against SIX2 and ECAD antisera. C-F) Representative co-immunofluorescence images of CFK section stained with isotype control antibodies (C) or SIX2 (red) and ECAD (green) antisera (D-F); nuclei were stained with DAPI. Strong SIX2 signal (red) (arrow) (D) was observed in the NP population that did not express ECAD (green) (arrow) (E); shown also on the merged image (arrow) (F); a weaker SIX2 signal was observed in pretubular aggregates (arrowhead) (D) that showed weak ECAD signal (arrowhead) (E); also shown on the merged image (arrowhead) (F); ECAD expression (concave arrowhead) (E) was observed in the ureteric bud that did not express SIX2 (concave arrowhead) (D); also shown on merged image (concave arrowhead) (F). Scale bars: 20 μm.](ejh-63-3-3049-g002){#fig002}

SIX1/ ECAD and SIX1/NCAM1 co-immunofluorescence analysis {#sec2-7}
--------------------------------------------------------

SIX1 is expressed in the MM of both mouse and human kidney. Notably, SIX1 expression continues in the cap mesenchyme (NPs) of the human kidney however, its expression becomes undetectable in the cap mesenchyme (NPs) of the mouse kidney.^[@ref46]^ Western blot analysis with SIX1 antiserum showed that SIX1 protein is expressed in the CFK ([Figure 4A](#fig004){ref-type="fig"}). To determine the expression of SIX1 in NPs and their early epithelial derivate structures in the nephrogenic zone of the dog fetal kidney co-immunofluorescence analyses of SIX1 antibody with ECAD or NCAM1 antisera were performed. Strong nuclear SIX1 signal was detected in cap mesenchymal cells surrounding the ECAD-positive ureteric bud cells ([Figure 4](#fig004){ref-type="fig"} B-D). SIX1 expression continued. in the pretubular aggregate and renal vesicle, structures identified by the expression of NCAM1 ([Figure 4 E-G](#fig004){ref-type="fig"}). In the distal segment of the Sshaped body, a weak SIX1 signal could be detected. These results indicate that the SIX1 distribution in CFK is similar to its reported distribution in the human fetal kidney but, is strikingly different from the mouse fetal kidney that does not express SIX1 in NPs.^[@ref46]^

PAX2/ECAD and PAX2/NCAM1 coimmunofluorescence analyses {#sec2-8}
------------------------------------------------------

PAX2 expression has been reported in NPs and their derivatives as well as in the ureteric bud; and PAX2 expression is essential for renal development in both lineages. ^[@ref47]^ To determine whether PAX2 protein is expressed in the CFK, we performed immunoblotting analysis on whole cell extracts prepared from the dog fetal kidney. PAX2 protein expression could be detected by western blot analysis ([Figure 5A](#fig005){ref-type="fig"}). PAX2 expression was detected in the ECAD-positive ureteric bud and cap mesenchymal cells surrounding the ureteric bud in the CFK ([Figure 5 B-D](#fig005){ref-type="fig"}). Strong PAX2 expression was also detected in NP-derivatives pretubular aggregates, renal vesicles and Sshaped bodies, structures identified by the expression of NCAM1 ([Figure 5 E-G](#fig005){ref-type="fig"}). PAX2 was localized to the nucleus in NPs and their derivatives and in the cells of the ureteric bud. PAX2 expression became undetectable in proximal tubules and distal tubules (*not shown*) however, PAX2 expression was detectable in differentiated collecting ducts in the medulla (*not shown*). Together, these results indicate that expression and localization of PAX2 in CFK is similar to human and mouse kidney.^[@ref47]^

ITGA8/ECAD and ITGA8/NCAM1 co-immunofluorescence analyses {#sec2-9}
---------------------------------------------------------

ITGA8 is a surface marker expressed in human and mouse kidney and used to purify cap mesenchymal cells with nephron-forming potential.^[@ref46],[@ref50],[@ref51]^ Immunoblot analysis with ITGA8 antiserum showed ITGA8 protein expression in the CFK ([Figure 6A](#fig006){ref-type="fig"}). Coimmunofluorescence analysis with ITGA8 antibody with Ecadherin or NCAM1 antisera was performed to determine its expression and distribution in the nephrogenic zone of the CFK. As a negative control, staining with isotype control (mouse and goat) antibodies was performed that did not show any signal ([Figure 6B](#fig006){ref-type="fig"}). ITGA8 signal was absent in the ECAD-positive ureteric bud ([Figure 6 C-E](#fig006){ref-type="fig"}). A strong ITGA8 signal was found at membrane of NPs cells that expressed NCAM1 ([Figure 6 F-H](#fig006){ref-type="fig"}). ITGA8 was also expressed in pre-tubular aggregates and renal vesicles (identified by ECAD and NCAM1 expression) albeit, at lower level ([Figure 6 C-H](#fig006){ref-type="fig"}). Very faint ITGA8 expression could also be detected in the distal segment of S-shaped body. ITGA8 expression was found in the mesangial cells of the developing and developed renal corpuscles (*not shown*). Given that ITGA8 is highly expressed and localized at the membrane in canine NPs and, its expression is relatively faint/weak in the early epithelial structures indicates that ITGA8 is very likely a suitable marker for the isolation of NPs from CFK.

![Expression of SIX2 and NCAM1 in the CFK. A) Whole kidney extracts were prepared from CFK and subjected to Immunoblot analysis with antiserum against NCAM1. B-D) Representative co-immunofluorescence images of CFK sections with SIX2 (red) and NCAM1 (green) antisera; nuclei were stained with DAPI; a subpopulation of SIX2-positive (red) (arrow) (B) expressed NCAM1 (green) (arrow) (C); also shown on the merged image (arrow) (D); a weaker SIX2 (arrowhead) (B) signal was observed in the renal vesicle cells that expressed strong NCAM1 signal (arrowhead) (C); also shown on the merged image (arrowhead) (D); NCAM1 expression (concave arrowhead) (C) was observed in NP-epithelial derivate structure, S-shaped body that did not express SIX2 (concave arrowhead) (B); also shown on the merged image (concave arrowhead) (D). Scale bars: 20 μm.](ejh-63-3-3049-g003){#fig003}

NCAD/ECAD and NCAD/NCAM1 co-immunofluorescence analyses {#sec2-10}
-------------------------------------------------------

NCAD, a mesenchymal stem cell marker is known to be expressed in mouse NPs however, its functional significance in the renal development remains unclear.^[@ref52],[@ref53]^ Western blot analysis with NCAD antiserum showed that NCAD protein is expressed in the CFK ([Figure 7A](#fig007){ref-type="fig"}). Coimmunofluorescence analysis of CFK with NCAD antibody and ECAD or NCAM1 antisera was performed. NCAD signal was absent in the ECAD-positive ureteric bud ([Figure 7 B-D](#fig007){ref-type="fig"}). Strong NCAD signal was found at membrane of cap mesenchymal cells and pretubular aggregates identified by NCAM1 ([Figure 7 E-G](#fig007){ref-type="fig"}). A weak NCAD signal could be detected in the NCAM1- positive S-shaped body.

![Expression of SIX1 in the CFK. A) Whole kidney extracts were prepared from CFK and subjected to Immunoblot analysis with antiserum against SIX1 antiserum. B-D) Representative co-immunofluorescence images of CFK sections with SIX1 (red) and ECAD (green) antisera; nuclei were stained with DAPI; a strong SIX1 signal (red) (arrow) (B) was observed in the NP population that did not express ECAD (green) (arrow) (C); shown also on the merged image (arrow) (D); SIX1 expression was observed in the renal vesicle (arrowhead) (B) cells that showed strong ECAD signal (arrowhead) (C); also shown on the merged image (arrowhead) (D); a weak and patchy SIX1 expression (concave arrowhead) (B) was observed in the S-shaped body that also expressed ECAD (concave arrowhead) (C); also shown on merged image (concave arrowhead) (D). E-G) Representative co-immunofluorescence images of CFK sections with SIX1 (red) and NCAM1 (green) antisera. SIX1-positive cells (red) (arrow) (E) expressed NCAM1 (green) (arrow) (F); also shown on the merged image (arrow) (G); SIX1 expression was observed in the renal vesicle cells (concave arrowhead) (E) that expressed strong NCAM1 signal (arrowhead) (F); shown also on the merged image (arrowhead) (G); a few SIX1-positive cells (concave arrowhead) (E) were observed in the S-shaped body identified by NCAM1 expression (concave arrowhead) (F); also shown on the merged image (concave arrowhead) (G). Scale bars: 20 μm.](ejh-63-3-3049-g004){#fig004}

Discussion {#sec1-4}
==========

In this study, molecular characterization of NPs and their early epithelial derivatives in the nephrogenic zone of the CFK with histological and immunofluorescence-based studies were performed. Specifically, this study describes the expression pattern of multiple transcription factors in the fetal kidney of dogs that have found to be important for the maintenance of NPs in mouse and human. This study also describes the expression pattern of various surface markers in canine NPs that have been used to isolate and enrich murine and human NPs.

SIX2 is a well-characterized and specific NP-marker and has a similar pattern of protein distribution and localization in the developing mouse and human kidney.^[@ref6],[@ref21],[@ref44],[@ref46]^ The expression pattern of SIX2 in canine NPs and their early derivates was found to be highly similar to its expression reported in mouse and human developing kidney.^[@ref54]^ SIX2 expression level has been used as a benchmark to gauge the purity and maintenance of NP-identity in various *in vitro* culture conditions.^[@ref4],[@ref7],[@ref13],[@ref14]^ Notably, SIX2 RNAprobe has been successfully used to sort NPs from the human kidney.^[@ref14]^ Given the conserved expression pattern of SIX2 in canine, mouse and human fetal kidney, the results of this study indicate that canine SIX2-specific RNA-probes could be used to isolate canine NPs and its NP-specific marker status could be exploited to gauge maintenance of NP identity in while testing various *in vitro* culture conditions for NPs.

![Expression of PAX2 in the CFK. A) Whole kidney extracts were prepared from CFK and subjected to Immunoblot analysis with antiserum against PAX2 antiserum. B-D) Representative co-immunofluorescence images of CFK sections with PAX2 (red) and ECAD (green) antisera; nuclei were stained with DAPI; a strong PAX2 signal (red) (arrow) (B) was observed in the NP population that did not express ECAD (green) (arrow) (C); shown also on the merged image (arrow) (D); PAX2 expression was observed in the S-shaped body (arrowhead) (B) cells that also expressed ECAD (arrowhead) (C); also shown on the merged image (arrowhead) (D); PAX2 expression (concave arrowhead) (B) was also observed in the ECAD-positive ureteric bud (concave arrowhead) (C); also shown on the merged image (concave arrowhead) (D). E-G) Representative co-immunofluorescence images of CFK sections with PAX2 (red) and NCAM1 (green) antisera; a subpopulation of PAX2-positive (red) (arrow) (E) expressed NCAM1 (green) (arrow) (F); also shown on the merged image (arrow) (G); a strong PAX2 (concave arrowhead) (E) signal was observed in the renal vesicle cells that expressed strong NCAM1 signal (concave arrowhead) (F); also shown on the merged image (concave arrowhead) (G); PAX2 expression (arrowhead) (E) was observed in NP-epithelial derivate structure, the S-shaped body identified by NCAM1 expression (arrowhead) (F); also shown on the merged image (arrowhead) (G). Scale bars: 20 μm.](ejh-63-3-3049-g005){#fig005}

In contrast to SIX2, the expression pattern of SIX1, a SIX2-related family member, in human and mice developing kidney is interestingly different.^[@ref46],[@ref54]^ SIX1 expression in mice is restricted to the MM in the early stages of renal development and becomes undetectable in NPs.^[@ref54]^ In the human kidney, SIX1 is expressed in the MM and its expression is maintained in the NP population.^[@ref46],[@ref54]^ In the human developing kidney, combined expression of SIX1 and SIX2 has been proposed to support NP selfrenewal and maintain nephrogenesis for a relatively longer gestation length in humans.^[@ref46]^ The combined expression of SIX1 and SIX2 has also been proposed to contribute to the generation of higher nephron number (average 1 million) in humans as compared to mice (average 20,000).^[@ref54]^ Similar to human, in canine kidney, both SIX1 and SIX2 expression were expressed at high levels in NPs of fetal kidney and may contribute to maintenance of NPs and generation of higher number of nephrons. The average number of nephrons in the adult canine kidney has been estimated to approximately 475,000 that develop in approximately 50-60 days.^[@ref55]^ It would be interesting to determine the role of SIX1 and SIX2 in the self-renewal of NPs in an *in vitro* canine NP culture model.

![Expression of ITGA8 in the CFK. A) Whole kidney extracts were prepared from CFK and subjected to Immunoblot analysis with antiserum against ITGA8 antiserum. B-E) Representative co-immunofluorescence images of CFK sections with isotype control antibodies (B) or ITGA8 (red) and ECAD (green) antisera; nuclei were stained with DAPI; a strong ITGA8 signal (red) (arrow) (C) was observed on surface of NP population that did not express ECAD (green) (arrow) (D); also shown on the merged image (arrow) (E); ITGA8 expression (arrowhead) (C) in the ECAD-positive renal vesicle (arrowhead) (D); also shown on the merged image (arrowhead) (E); a weaker ITGA8 signal (concave arrowhead) (C) was detected in the distal segment of the ECAD-positive S-shaped body (concave arrowhead) (D); also shown on the merged image (concave arrowhead) (E). F-H) Representative co-immunofluorescence images of CFK sections with ITGA8 (red) and NCAM1 (green) antisera; a subpopulation of ITGA8-positive (red) (arrow) (F) expressed strong NCAM1 signal (green) (arrow) (G); also shown on the merged image (arrow) (H); ITGA8 signal (arrowhead) (F) in the NCAM1-positive renal vesicle (arrowhead) (G); also shown on the merged image (arrowhead) (H). ITGA8 expression (concave arrowhead) (F) in the distal segment of the S-shaped body identified by NCAM1 expression (concave arrowhead) (G); also shown on the merged image (arrowhead) (H). Scale bars: 20 μm.](ejh-63-3-3049-g006){#fig006}

PAX2 expression pattern in the CFK has strong similarities to its expression pattern in the mouse and human developing kidney.^[@ref47]^ PAX2 plays indispensable roles in various stages of renal development in multiple cell types.^[@ref56]^ Global deletion of Pax2 results in renal agenesis due to degeneration of the nephric ducts.^[@ref56]^ PAX2 regulates the outgrowth of the ureteric bud by regulating glial derived nerve growth factor (GDNF) and c-Ret expression.^[@ref49],[@ref56],[@ref59]^ PAX2 also regulates branching morphogenesis of the ureteric bud; mice expressing one mutant allele of Pax2^1Neu^, show reduced branching of the ureteric bud which contributes to renal hypoplasia.^[@ref56],[@ref60]^ PAX2 regulates differentiation of NPs, by regulating mesenchymal to epithelial transition.^[@ref49],[@ref56],[@ref61]^ Recently, it has been shown that PAX2 in NPs is essential to maintain their identity and PAX2-deficent NPs transdifferentiate into interstitiallike cells.^[@ref47]^ In CFK, PAX2 is localized in NPs and their early epithelial derivates as well as in the ureteric bud. The role of PAX2 in the renal development of dogs remains to be determined.

Notably, PAX2 mutations cause renal coloboma syndrome in humans.^[@ref62],[@ref63]^ SIX2 mutations cause renal hypodysplasia and SIX1 mutations are known to cause brachio- oto-renal syndrome in humans.^[@ref43],[@ref54]^ Knockout mouse models have also identified indispensable roles of these three genes in the renal development.^[@ref6],[@ref47],[@ref64]^ In dog, renal dysplasia cases are known to occur frequently; however, its molecular basis is not well understood.^[@ref28],[@ref33],[@ref35]^ This study reports the expression pattern of transcription factors SIX2, SIX1 and PAX2 in the CFK and highlights the conserved and distinct features in relation to the human and mouse kidney. These genes could be carefully analyzed in dogs while screening cases of renal maldevelopment to determine candidate genes for renal dysplasia.

Development and standardization of strategies for the isolation and expansion of canine NPs are essential to develop NP-based therapeutic approaches for canine chronic kidney disease. This study reports the expression and localization of three surface markers ITGA8, NCAM1 and NCAD in the CFK. ITGA8 was found to be expressed highly in the cell surface of canine NPs and expressed at very low levels only in a sub-population of cells in NPderived early epithelial structures Similar expression pattern of ITGA8 has been reported in mice and human fetal kidney.^[@ref50]^ ITGA8, has been successfully used to sort and enrich NPs from the mouse and human kidney.^[@ref46],[@ref51]^ Following the removal of the renal capsule, underlying NP population is preferentially dissociated by partial/incomplete enzymatic digestion for a short period of time. By this method, fewer cells from early epithelial derivatives are likely dissociated and leading to NP enrichment. Furthermore, to reduce contaminating interstitial cells negative selection for PDFRA has been found to be useful.^[@ref4],[@ref51],[@ref65],[@ref66]^ Single cell RNA-sequencing profiling has revealed that NPs from human and mouse kidneys are ITGA8^+^/PDGFA^-^ and sorting cells based on the expression of these two markers results in high enrichment of NPs.^[@ref51],[@ref66]^ Recently, it has been shown that the most of the ITGA8^+^/PDFGA^-^ population from the iPSC-derived NPs were SIX2-positive NPs that robustly generated epithelial cells of glomeruli and renal tubules following stimulation with differentiating signals.^[@ref65]^ Future studies to determine the expression of PDGFA or other interstitial cell surface markers in CFK will be useful to select marker(s) for negative selection to minimize contaminating interstitial cells.

![Expression of NCAD in the CFK. A) Whole kidney extracts were prepared from CFK and subjected to Immunoblot analysis with antiserum against NCAD antiserum. B-D) Representative co-immunofluorescence images of CFK sections with NCAD (red) and ECAD (green) antisera; nuclei were stained with DAPI; a strong NCAD signal (red) (arrow) (B) was observed on surface of NP population that did not express ECAD (green) (arrow) (C); shown also on the merged image (arrow) (D); NCAD expression (arrowhead) (B) was observed in the ECAD-positive pretubular aggregates (arrowhead) (C); also shown on the merged image (arrowhead) (D). EG) Representative co-immunofluorescence images of CFK sections with NCAD (red) and NCAM1 (green) antisera. NCAD-positive cells (red) (arrow) (E) also express strong NCAM1 signal (green) (arrow) (F); also shown on the merged image (arrow) (G); NCAD expression (concave arrowhead) (E) the S-shaped body identified by NCAM1 expression (concave arrowhead) (F); also shown on the merged image (concave arrowhead) (G). Scale bars: 20 μm.](ejh-63-3-3049-g007){#fig007}

NCAM1 has also been utilized to enrich human NP population by magnetic-activated cell sorting and NCAM1-positive cells have been shown to have nephron-forming potential and the ability to cause renal repair following chronic renal failure.^[@ref32],[@ref67]^ However, cells sorted based solely on NCAM1 expression contained both SIX2- positive and SIX2-negative population.^[@ref32]^ Further studies reported that NCAM1^+^/CD133^-^ -based strategy led to better enrichment of multipotent renal stem cells as it removes NCAM^+^/CD133^+^ cells of early epithelial derivative structures and immature tubules.^[@ref68]^ To remove cells from mature renal tubules negative selection for the third marker EPCAM was found to be useful.^[@ref4],[@ref69]^ The expression of CD133 and EPCAM in the embryonic and CFK remains to be elucidated.

Canine NPs also expressed high levels of NCAD and a weak NCAD signal was also expressed in early epithelial derivates. NCAD is known to be expressed in the NP population of the fetal mouse kidney.^[@ref52]^ Together, the results of this study suggest that high expression levels of these markers at the canine NP cell surface makes them suitable candidates for the sorting and enrichment of NP population from the developing canine kidneys.

In summary, to our knowledge, this is the first report that describes the molecular features of NPs and their derivatives in CFK and highlights the similarities and distinct features between their mouse and human counterparts. These results provide an important framework that would facilitate identification, isolation and culture of canine NPs as well as their functional characterization to develop into nephrons.

We thank Dr. Rachel Tears from Alabama Animal Alliance Spay Neuter Clinic for providing gravid uteri. We also thank Dr. Gopal Reddy (Professor, Tuskegee University College of Veterinary Medicine - TUCVM) for sharing research supplies. We also thank RCMI Microscope Facility, and Anatomic Pathology Facility at TUCVM. We thank Dr. William H Walker (Associate Professor, University of Pittsburgh) for his help in editing the manuscript.

[^1]: Authors' contributions: RF, AIA, Western blots analyses; PP, study design, co-immunofluorescence performing, contribution to the immunoblot experiments, manuscript drafting. All the authors read and approved the final version of the manuscript.

[^2]: Conflict of interests: The authors declare that they have no competing interests.
